Stress resilience during the coronavirus pandemic

dc.contributor.authorVinkers, Christiaan H.
dc.contributor.authorvan Amelsvoort, Therese
dc.contributor.authorBisson, Jonathan I.
dc.contributor.authorBranchi, Igor
dc.contributor.authorCryan, John F.
dc.contributor.authorDomschke, Katharina
dc.contributor.authorHowes, Oliver D.
dc.contributor.authorManchia, Mirko
dc.contributor.authorPinto, Luisa
dc.contributor.authorde Quervain, Dominique
dc.contributor.authorSchmidt, Mathias V.
dc.contributor.authorvan der Wee, Nic J. A.
dc.contributor.funderMedical Research Councilen
dc.date.accessioned2022-03-31T14:55:17Z
dc.date.available2022-03-31T14:55:17Z
dc.date.issued2020-01
dc.date.updated2022-03-31T14:10:01Z
dc.description.abstractThe epidemic of the 2019 novel coronavirus SARS-CoV-2, causing the coronavirus disease 2019 (COVID-19) is a global public health emergency with multifaceted severe consequences for people's lives and their mental health. In this article, as members of the European College of Neuropsychopharmacology (ECNP) Resilience, we will discuss the urgent need for a focus on resilience during the current coronavirus pandemic. Resilience is pivotal to cope with stress and vital to stay in balance. We will discuss the importance of resilience at the individual and societal level, but also the implication for patients with a psychiatric condition and health care workers. We not only advocate for an increased focus on mental health during the coronavirus pandemic but also highlight the urgent need of augmenting our focus on resilience and on strategies to enhance it.en
dc.description.sponsorshipMedical Research Council, United Kingdom (Grant No. MC_U120097115/MR)en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationVinkers, C. H., van Amelsvoort, T., Bisson, J. I., Branchi, I., Cryan, J. F., Domschke, K., Howes, O. D., Manchia, M., Pinto, L., de Quervain, D., Schmidt, M. V. and van der Wee, N. J. A. (2020) 'Stress resilience during the coronavirus pandemic', European Neuropsychopharmacology, 35, pp. 12-16. doi: 10.1016/j.euroneuro.2020.05.003en
dc.identifier.doi10.1016/j.euroneuro.2020.05.003en
dc.identifier.endpage16en
dc.identifier.issn0924-977X
dc.identifier.journaltitleEuropean Neuropsychopharmacologyen
dc.identifier.startpage12en
dc.identifier.urihttps://hdl.handle.net/10468/13023
dc.identifier.volume35en
dc.language.isoenen
dc.publisherElsevier B.V.en
dc.rights© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license. (http://creativecommons.org/licenses/by/4.0/)en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en
dc.subjectCoronaen
dc.subjectCoronavirusen
dc.subjectCOVID-19en
dc.subjectIntervention strategiesen
dc.subjectMental healthen
dc.subjectPandemicen
dc.subjectPsychiatric disordersen
dc.subjectResilienceen
dc.subjectSARS-CoV-2en
dc.subjectStress vulnerabilityen
dc.titleStress resilience during the coronavirus pandemicen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1-s2.0-S0924977X20301322-main.pdf
Size:
355.96 KB
Format:
Adobe Portable Document Format
Description:
Published Version
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description: